Posted by creepy on October 31, 2020, at 0:03:40
In reply to Rexulti, posted by phidippus on October 28, 2020, at 15:29:52
personally I think the risk versus reward ratio for AP's in depression is unappealing. They marketed these for unipolar depression and now theyre marketing heavily for new meds for tardive dyskinesia. Doesnt seem very ethical.
I would stay clear of AP's unless I had psychosis or hypomania.
poster:creepy
thread:1112378
URL: http://www.dr-bob.org/babble/20201025/msgs/1112396.html